semaglutide fda approved approves obesity drug that helped people cut weight 15% Semaglutide Receives FDA Approval for

Signs Your Dose May Need Adjustment Signs Your Dose May Be Too Low No improvement in sleep quality after 3-4 weeks Minimal energy changes after 6-8 weeks Lab work shows IGF-1 levels unchanged from baseline Signs Your Dose May Be Too High Water retention (puffy hands, ankles, face) Tingling or numbness in extremities Joint stiffness or discomfort Headaches, particularly in the morning Carpal tunnel-like symptoms If you experience these symptoms, contact your provider

Residue in your mouth may affect absorption

LiverTox - NCBI Bookshelf

If youre considering weight loss medicine, its important to understand who qualifies for GLP-1s.* These medications are intended for people with type 2 diabetes and obesity

Report concerning findings to a healthcare provider promptly

Sometimes were haggling over doses, says Dushay, who wrote about this topic in an op-ed for STAT in February